Edition:
United States

Acura Pharmaceuticals Inc (ACUR.O)

ACUR.O on Consolidated Issue listed on NASDAQ Capital Market

1.66USD
23 Sep 2016
Change (% chg)

$-0.01 (-0.60%)
Prev Close
$1.67
Open
$1.67
Day's High
$1.87
Day's Low
$1.46
Volume
298,650
Avg. Vol
43,361
52-wk High
$3.52
52-wk Low
$1.40

ACUR.O

Chart for ACUR.O

About

Acura Pharmaceuticals, Inc. is a pharmaceutical company. The Company is engaged in the research, development and commercialization of technologies and products intended to address medication abuse and misuse. The Company has discovered and developed three platform technologies, which can be used to develop multiple products. The... (more)

Overall

Beta: 2.26
Market Cap(Mil.): $19.64
Shares Outstanding(Mil.): 11.83
Dividend: --
Yield (%): --

Financials

  ACUR.O Industry Sector
P/E (TTM): -- 42.52 36.60
EPS (TTM): -0.86 -- --
ROI: -117.74 -0.26 13.91
ROE: -351.36 -3.05 14.82

BRIEF-Acura Pharmaceuticals qtrly loss per share $0.28

* Acura pharmaceuticals inc says revenues for quarter were $257 thousand compared to $341 thousand in q2 of 2015

Aug 08 2016

BRIEF-Acura Pharmaceuticals reports Q1 net loss $0.28 per diluted share

* Reported net loss of $3.4 million for Q1 2016 or $0.28 per diluted share

May 02 2016

BRIEF-Acura Pharmaceutical's Limitx technology successfully demonstrates oral abuse deterrence

* Acura pharmaceutical's Limitx(TM) technology successfully demonstrates oral abuse deterrence

Apr 13 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ Quantitative Report
$104.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.